Survival after recurrence of Ewing tumors: the St Jude Children's Research Hospital experience, 1979-1999 (Q77783931)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11900241%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

Survival after recurrence of Ewing tumors: the St Jude Children's Research Hospital experience, 1979-1999 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11900241%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

Carlos Rodriguez-Galindo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11900241%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Catherine A Billups

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11900241%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Larry E Kun

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11900241%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Bhaskar N Rao

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11900241%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Charles B Pratt

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11900241%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Thomas E Merchant

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11900241%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Victor M Santana

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11900241%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Alberto S Pappo

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11900241%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 January 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11900241%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11900241%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

94

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11900241%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11900241%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

561-569

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11900241%20AND%20SRC:MED&resulttype=core&format=json

Chemotherapy dose-intensification for pediatric patients with Ewing's family of tumors and desmoplastic small round-cell tumors: a feasibility study at St. Jude Children's Research Hospital

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10192

7 January 2021

Italian Cooperative Study for the treatment of children and young adults with localized Ewing sarcoma of bone: a preliminary report of 6 years of experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10192

7 January 2021

Evaluation of prognostic factors in a tumor volume-adapted treatment strategy for localized Ewing sarcoma of bone: the CESS 86 experience. Cooperative Ewing Sarcoma Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10192

7 January 2021

Local therapy and other factors influencing site of relapse in patients with localised Ewing's sarcoma. United Kingdom Children's Cancer Study Group (UKCCSG)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10192

7 January 2021

Intergroup Ewing's Sarcoma Study: local control related to radiation dose, volume, and site of primary lesion in Ewing's sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10192

7 January 2021

Long-term results in 144 localized Ewing's sarcoma patients treated with combined therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10192

7 January 2021

Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10192

7 January 2021

Long-term results from the first UKCCSG Ewing's Tumour Study (ET-1). United Kingdom Children's Cancer Study Group (UKCCSG) and the Medical Research Council Bone Sarcoma Working Party

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10192

7 January 2021

Multidisciplinary treatment of primary Ewing's sarcoma of bone. A 6-year experience of a European Cooperative Trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10192

7 January 2021

Combined therapy of localized Ewing's sarcoma of bone: analysis of results in 100 patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10192

7 January 2021

Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10192

7 January 2021

Significance of surgical margin on the prognosis of patients with Ewing's sarcoma. A report from the Cooperative Ewing's Sarcoma Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10192

7 January 2021

Treatment of children with relapsed soft tissue sarcoma: report of the German CESS/CWS REZ 91 trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10192

7 January 2021

Ifosfamide-containing chemotherapy in Ewing's sarcoma: The Second United Kingdom Children's Cancer Study Group and the Medical Research Council Ewing's Tumor Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10192

7 January 2021

Therapy for localized Ewing's sarcoma of bone

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10192

7 January 2021

Ifosfamide plus etoposide in newly diagnosed Ewing's sarcoma of bone

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10192

7 January 2021

Long-term survival in patients with Ewing's sarcoma relapsing after completing therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10192

7 January 2021

Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone: intergroup study IESS-II

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10192

7 January 2021

Ewing's tumors with primary lung metastases: survival analysis of 114 (European Intergroup) Cooperative Ewing's Sarcoma Studies patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10192

7 January 2021

Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10192

7 January 2021

A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10192

7 January 2021

Pelvic Ewing sarcoma: a retrospective analysis of 241 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10192

7 January 2021

Multimodal therapy for the management of localized Ewing's sarcoma of pelvic and sacral bones: a report from the second intergroup study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10192

7 January 2021

Local recurrence, rate and sites of metastases, and time to relapse as a function of treatment regimen, size of primary and surgical history in 62 patients presenting with non-metastatic Ewing's sarcoma of the pelvic bones

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10192

7 January 2021

Effect of low-dose radiation therapy when combined with surgical resection for Ewing sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10192

7 January 2021

Ewing's sarcoma: local tumor control and patterns of failure following limited-volume radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10192

7 January 2021

Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10192

7 January 2021

Ifosfamide/carboplatin/etoposide (ICE) for recurrent malignant solid tumors of childhood: a Pediatric Oncology Group Phase I/II study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10192

7 January 2021

Response of pediatric malignant solid tumors following ifosfamide or ifosfamide/carboplatin/etoposide: a single hospital experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10192

7 January 2021

Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10192

7 January 2021

Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10192

7 January 2021

Identifiers

DOI

10.1002/CNCR.10192

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11900241%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference